Dren Bio raises $350M to get blood cancer drug onto market in 2027
Dren Bio has raised $350 million, hoping to get its lead blood cancer drug onto the market by the end of 2027, the California drug developer exclusively told Endpoints News. The Thursday morning haul will ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.